Response Biomedical Corporation CEO resigns

Response Biomedical Corporation recently announced the resignation of its chief executive officer, S. Wayne Kay, effective immediately.

Peter Thompson was chosen to act as executive chairman and interim CEO while a new CEO is found. Response’s board of directors has hired an executive search firm to identify and hire a new manager as quickly as possible, according to

“The numerous contributions made by Mr. S. Wayne Kay during his tenure at Response are much appreciated by the board,” Thompson said, reports. “We thank Wayne for his leadership and wish him well in his future endeavors.”

Kay has served as a director and CEO of Response since September 2007. No reason was given for his departure from the company.

Response is best known for developing and marketing rapid on-site diagnostic tests for the detection of biological agents. Its RAMP platform is capable of field testing for anthrax, ricin and smallpox. United Nations weapons inspectors used the RAMP system while searching for biological weapons in Iraq.

The RAMP system consists of a portable scanning fluorescence reader and single-use disposable test cartridges. In order to use the system, a small sample is placed on the test cartridge and then inserted into the reader. Results are generally ready minutes later.